Patrick J. Kerins - 29 Jan 2024 Form 4 Insider Report for Sagimet Biosciences Inc. (SGMT)

Reporting relationship: 10%+ Owner
Issuer ticker: SGMT
Reported as of: 29 Jan 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 31 Jan 2024, 16:59:07 UTC
Prior SEC filing: 05 Dec 2023
Next SEC filing: 06 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Stephanie Brecher, attorney-in-fact

Key filing fact

Patrick J. Kerins filed Form 4 for Sagimet Biosciences Inc. (SGMT) on 31 Jan 2024.

Key facts

This page summarizes Patrick J. Kerins's Form 4 filing for Sagimet Biosciences Inc. (SGMT).
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 31 Jan 2024, 16:59.

Change

Previous filing in this sequence was filed on 05 Dec 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SGMT transaction

Series A Common Stock

Other

Transaction value: $0
Shares: -850,000
Change %: -22%
Price: $0.000000
Shares after: 3,000,275
Date: 29 Jan 2024
Ownership: See Note 2
Footnotes: F1, F2

SGMT transaction

Series A Common Stock

Other

Transaction value: $0
Shares: +260,950
Change %
Price: $0.000000
Shares after: 260,950
Date: 29 Jan 2024
Ownership: See Note 4
Footnotes: F3, F4

SGMT transaction

Series A Common Stock

Other

Transaction value: $0
Shares: -260,950
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 Jan 2024
Ownership: See Note 4
Footnotes: F4, F5

SGMT transaction

Series A Common Stock

Other

Transaction value: $0
Shares: +13,139
Change %
Price: $0.000000
Shares after: 13,139
Date: 29 Jan 2024
Ownership: Direct
Footnotes: F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Patrick J. Kerins is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 6 footnotes

Footnote F1

New Enterprise Associates 13, L.P. ("NEA 13") made a pro rata distribution of 850,000 shares of Series A Common Stock of the Issuer to its general partner and limited partners for no consideration on January 29, 2024.

Footnote F2

The Reporting Person is a director of NEA 13 GP, LTD ("NEA 13 LTD"), which is the sole general partner of NEA Partners 13, L.P. ("NEA Partners 13"). NEA Partners 13 is the sole general partner of NEA 13, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 13 in which the Reporting Person has no pecuniary interest.

Footnote F3

NEA Partners 13 received 260,950 shares of Series A Common Stock of the Issuer in the distribution made by NEA 13 on January 29, 2024.

Footnote F4

The Reporting Person is a director of NEA 13 LTD, the sole general partner of NEA Partners 13, the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA Partners 13 in which the Reporting Person has no pecuniary interest.

Footnote F5

NEA Partners 13 made a pro rata distribution for no consideration of an aggregate of 260,950 shares of Series A Common Stock of the Issuer to its limited partners on January 29, 2024.

Footnote F6

The Reporting Person received 13,139 shares of Series A Common Stock of the Issuer in the distribution by NEA Partners 13 on January 29, 2024.